ClouDr Group (HKSE:09955) Ending Cash Position : HK$266 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group Ending Cash Position?

ClouDr Group's Ending Cash Position for the quarter that ended in Dec. 2023 was HK$266 Mil.

ClouDr Group's quarterly Ending Cash Position declined from Dec. 2022 (HK$279 Mil) to Jun. 2023 (HK$213 Mil) but then increased from Jun. 2023 (HK$213 Mil) to Dec. 2023 (HK$266 Mil).

ClouDr Group's annual Ending Cash Position declined from Dec. 2021 (HK$1,335 Mil) to Dec. 2022 (HK$279 Mil) and declined from Dec. 2022 (HK$279 Mil) to Dec. 2023 (HK$266 Mil).

ClouDr Group Ending Cash Position Historical Data

The historical data trend for ClouDr Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group Ending Cash Position Chart

ClouDr Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

668.95

1,083.75

1,335.37

278.82

266.20

ClouDr Group Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial			1,335.37	612.28	278.82	212.64	266.20

ClouDr Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

ClouDr Group's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	273.087	+	-6.889
	=	266

ClouDr Group's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	212.637	+	53.561
	=	266

ClouDr Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of ClouDr Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ClouDr Group (HKSE:09955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

H3L:Germany

Address

No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.cloudr.cn

ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

Executives

Trident Trust Company (hk) Limited	2301 Trustee
Data Vantage Development Limited	2201 Interest of corporation controlled by you
Kuang Ming	2201 Interest of corporation controlled by you
Prime Forest Assets Limited	2101 Beneficial owner
Shang Hai Qi Ji Ke Ji He Huo Qi Ye You Xian He Huo
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Zhao Yin Guo Ji Jin Rong You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Ho Chi Sing	2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd.
Zhou Quan	2201 Interest of corporation controlled by you
Idg China Venture Capital Fund Gp Iv Associates Ltd.	2201 Interest of corporation controlled by you
Haoyuan Health Limited	2101 Beneficial owner
Yass Jeffrey Steven

ClouDr Group (HKSE:09955) Headlines

No Headlines